Abstract
The current state of knowledge about β-blockers in treating hypertension and their comparative pharmacology is reviewed. Some new developments in antihypertensive therapy, such as converting-enzyme inhibitors and calcium antagonistic drugs are discussed and their place vis-a-vis the β-blockers analysed.
Original language | English (US) |
---|---|
Pages (from-to) | 1-4 |
Number of pages | 4 |
Journal | Drugs |
Volume | 25 |
Issue number | 2 |
DOIs | |
State | Published - Jun 1983 |
ASJC Scopus subject areas
- Pharmacology (medical)